Biotech lags market rebound

Despite an upturn in the general markets on Monday, the BioCentury 100 was unable to recapture any portion of last Friday's 13 percent loss, as the index slipped a further 2 percent on Monday. The general

Read the full 365 word article

How to gain access

Continue reading with a
two-week free trial.